Basilea Pharmaceutica AG (BSLN.SW)

CHF 41.65

(0.24%)

Operating Expenses Summary of Basilea Pharmaceutica AG

  • Basilea Pharmaceutica AG's latest annual operating expenses in 2023 was 111.63 Million CHF , up 6.71% from previous year.
  • Basilea Pharmaceutica AG's latest quarterly operating expenses in 2024 Q2 was 15.32 Million CHF , down 0.0% from previous quarter.
  • Basilea Pharmaceutica AG reported a annual operating expenses of 104.61 Million CHF in annual operating expenses 2022, down -14.86% from previous year.
  • Basilea Pharmaceutica AG reported a annual operating expenses of 122.87 Million CHF in annual operating expenses 2021, down -3.12% from previous year.
  • Basilea Pharmaceutica AG reported a quarterly operating expenses of 73.62 Million CHF for 2023 Q4, down 0.0% from previous quarter.
  • Basilea Pharmaceutica AG reported a quarterly operating expenses of 38.01 Million CHF for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Basilea Pharmaceutica AG (2023 - 2002)

Historical Annual Operating Expenses of Basilea Pharmaceutica AG (2023 - 2002)

Year Operating Expenses Operating Expenses Growth
2023 111.63 Million CHF 6.71%
2022 104.61 Million CHF -14.86%
2021 122.87 Million CHF -3.12%
2020 126.83 Million CHF -4.43%
2019 132.71 Million CHF 315.43%
2018 31.94 Million CHF -35.87%
2017 49.81 Million CHF -12.24%
2016 56.76 Million CHF 4.58%
2015 54.27 Million CHF 80.88%
2014 30 Million CHF 43.66%
2013 20.88 Million CHF -80.07%
2012 104.78 Million CHF -13.42%
2011 121.03 Million CHF 1438.14%
2010 7.86 Million CHF -94.63%
2009 146.39 Million CHF -10.84%
2008 164.2 Million CHF 13.74%
2007 144.36 Million CHF 51.78%
2006 95.11 Million CHF 16.94%
2005 81.33 Million CHF 7.01%
2004 76 Million CHF 35.09%
2003 56.26 Million CHF -10.73%
2002 63.02 Million CHF 0.0%

Peer Operating Expenses Comparison of Basilea Pharmaceutica AG

Name Operating Expenses Operating Expenses Difference
Addex Therapeutics Ltd 11.89 Million CHF -838.563%
BB Biotech AG -199.56 Million CHF 155.939%
Evolva Holding SA 89.66 Million CHF -24.506%
Idorsia Ltd 400.38 Million CHF 72.118%
Kuros Biosciences AG 36.21 Million CHF -208.222%
Molecular Partners AG 20.3 Million CHF -449.872%
Relief Therapeutics Holding AG 114.94 Million CHF 2.876%
Santhera Pharmaceuticals Holding AG 31.33 Million CHF -256.263%